出版物 打印 Okcu I, Durani U, Levy RJ, Moustafa MA, Rosenthal AC, Delaune R, Larson DP, Witzig TE, Howard MT, Wiseman GA, Iqbal M, Comfere NI, Shah N, Breitkreutz L, Bold MS, Wang Y, Lunn BW, Lester SC, Breen WG, Hoppe BS, Hill CR, Kimball VM, Nedved AN, King RL, Habermann TM, Khurana A. Impact of a Virtual Multidisciplinary Lymphoma Tumor Board on Clinical Decision-Making. Mayo Clin Proc Innov Qual Outcomes. 2026 Dec; 10 (6):100764 Epub 2026 Sept 22 View PubMed Aizpuru M, Boland JM, Lunn BW, Saddoughi SA, Shen KR, Cassivi SD, Wigle DA, Reisenauer JS, Tapias LF. FDG-PET/CT SUVmax Predicts Recurrence Risk of Resected Pleuropulmonary Solitary Fibrous Tumors. JTO Clin Res Rep. 2026 Feb; 7(2):100942. Epub 2025 Dec 13. View PubMed Tapias LF, Shen R, Cassivi SD, Reisenauer JS, Lunn BW, Lechtenberg BJ, Nichols FC, Wigle DA, Blackmon SH. Impact of FDG PET Standardized Uptake Value in Resected Clinical Stage IA Non-Small Cell Lung Cancer. Ann Thorac Surg. 2024 May; 117(5):1017-1023. Epub 2023 Apr 19. View PubMed Bartlett DJ, Takahashi H, Bach CR, Lunn B, Thorpe MP, Broski SM, Packard AT, Fletcher JG, Navin PJ. Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvis. Abdom Radiol (NY). 2023 Dec; 48 (12):3624-3633 Epub 2023 May 05 View PubMed Lunn B, Yasir S, Lam-Himlin D, Menias CO, Torbenson MS, Venkatesh SK. Anastomosing hemangioma of the liver: a case series. Abdom Radiol (NY). 2019 Aug; 44 (8):2781-2787 View PubMed Lunn BW, Littrell LA, Wenger DE, Broski SM. (18)F-FDG PET/CT and MRI features of myxoid liposarcomas and intramuscular myxomas. Skeletal Radiol. 2018 Dec; 47 (12):1641-1650 Epub 2018 June 20 View PubMed Bricker-Anthony C, d'Surney L, Lunn B, et al. Erythropoietin either prevents or exacerbates retinal damage from eye trauma depending on treatment timing Optom Vis Sci. 2017; 94(1):20. PST-20516061 主页 出版物